Boston Scientific Inc. (NYSE: BSX) is no stranger to lawsuits, usually from unhappy consumers. But an entire country?
The medical device maker, based in Natick, Massachusetts, continues to face a lawsuit from the Republic of Iraq, whose government alleges BSX and 91 other global companies paid kickbacks to Saddam Hussein’s regime in exchange for business under the troubled United Nations Oil for Food Program.
According to the original complaint, filed June 2008 in U.S. District Court for the Southern District of New York, Saddam Hussein’s regime reaped billions of dollars in illegal payments from global companies, including BSSA, Boston Scientific’s French subsidiary, by inflating prices for goods and services with bogus transportation and service fees.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Here’s how the scandal worked: After the 1991 Gulf War, the United Nations established the Oil for Food program. Iraq could sell a limited amount of oil and use the proceeds from a UN-monitored escrow account to purchase humanitarian goods like food and medicine for the Iraqi people.
However, Saddam Hussein’s regime siphoned money from the account by adding bogus fees to the prices it charged the companies. For example, companies would directly pay the regime a minimum 10 percent “after-sales-service fee” of the total shipment. To hide the payment from UN monitors, the regime would just add the fee to the original price of the contract.
In the lawsuit, Iraq alleges the companies knew these fees were kickbacks but paid them anyway so they could continue to do business in the country.
“The defendants were therefore put to a stark choice — agree to enter into an illegal and fraudulent conspiracy to divert humanitarian funds from the UN OFFP Escrow Account (and thus the Iraqi people) or forgo the opportunity to profit from sales under the Programme,” the lawsuit says. “All of the defendants chose to join the conspiracy.”
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Iraqi government calculates BSX paid Hussein’s regime at least $28,717 to in order to sell $315,911 in goods under the Oil for Food Program. That’s a relatively small amount, when you consider there were far worse alleged offenders: AWB Ltd. of Australia paid the regime $221.7 million to sell $6.8 million worth of wheat for $2.3 billion.
Paul Donovan, a company spokesman, did not return an e-mail seeking comment.
In its latest 10-K filing, Boston Scientific says it intends to “vigorously defend against its allegations.” In January, the company filed a motion to dismiss the lawsuit, which is still pending.
